Insulin lispro Subcutaneous and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
Determining the interaction of Insulin lispro Subcutaneous and Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Nuwiq recombinant
- Insulin lispro Subcutaneous-NuZole
- Insulin lispro Subcutaneous-Nuzyra
- Insulin lispro Subcutaneous-Nuzyra (Omadacycline Injection)
- Insulin lispro Subcutaneous-Nuzyra (Omadacycline Tablets)
- Insulin lispro Subcutaneous-Nuzyra Intravenous
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Insulin NPH
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Insulin NPH (Vials)
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Insulin NPH and Insulin Regular
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Insulin NPH and Insulin Regular (Vials)